Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-21 9:00 pm Unchanged | 2024-10-17 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 9.800% | 0 (Unchanged) | Filing History |
| 2024-10-08 6:48 pm Sale | 2024-10-04 | 13D | MoonLake Immunotherapeutics MLTX | BIOTECHNOLOGY VALUE FUND L P | 19,751,284 31.400% | -2,000,000 (-9.19%) | Filing History |
| 2024-09-11 7:42 pm Sale | 2024-09-02 | 13G | Calliditas Therapeutics AB (publ) CALT | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -6,260,311 (Position Closed) | Filing History |
| 2024-08-23 4:34 pm Purchase | 2024-08-13 | 13G | Avalo Therapeutics, Inc. AVTX | BIOTECHNOLOGY VALUE FUND L P | 967,299 9.990% | 967,299 (New Position) | Filing History |
| 2024-08-19 6:48 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | BIOTECHNOLOGY VALUE FUND L P | 340,660 9.990% | 340,660 (New Position) | Filing History |
| 2024-07-19 4:30 pm Unchanged | 2024-07-17 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.300% | 0 (Unchanged) | Filing History |
| 2024-06-10 5:01 pm Purchase | 2024-05-30 | 13G | Celcuity Inc. CELC | BIOTECHNOLOGY VALUE FUND L P | 3,466,000 9.900% | 3,466,000 (New Position) | Filing History |
| 2024-05-30 4:51 pm Purchase | 2024-05-20 | 13G | Foghorn Therapeutics Inc. FHTX | BIOTECHNOLOGY VALUE FUND L P | 5,552,341 9.990% | 5,552,341 (New Position) | Filing History |
| 2024-05-17 5:07 pm Unchanged | 2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% | 0 (Unchanged) | Filing History |
| 2024-05-17 5:07 pm Purchase | 2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% | 257,622 (New Position) | Filing History |
| 2024-03-05 4:59 pm Unchanged | 2024-02-29 | 13D | MoonLake Immunotherapeutics MLTX | BIOTECHNOLOGY VALUE FUND L P | 21,751,284 34.600% | 0 (Unchanged) | Filing History |
| 2024-02-22 4:45 pm Unchanged | 2024-02-20 | 13G | enGene Holdings Inc. ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 7.200% | 0 (Unchanged) | Filing History |
| 2024-02-14 10:30 am Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,360,941 (Position Closed) | Filing History |
| 2024-02-14 10:28 am Sale | 2023-12-31 | 13G | Rein Therapeutics Inc. RNTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -236,835 (Position Closed) | Filing History |
| 2024-02-14 10:26 am Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.900% | 3,219,306 (+85.15%) | Filing History |
| 2024-02-14 10:24 am Purchase | 2023-12-31 | 13G | Aravive, Inc. ARAV | BIOTECHNOLOGY VALUE FUND L P | 8,164,510 9.990% | 2,055,452 (+33.65%) | Filing History |
| 2024-02-14 10:22 am Purchase | 2023-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN | BIOTECHNOLOGY VALUE FUND L P | 5,418,122 9.990% | 5,418,122 (New Position) | Filing History |
| 2024-02-14 10:20 am Sale | 2023-12-31 | 13G | Bionomics Limited BNOX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -14,174,157 (Position Closed) | Filing History |
| 2024-02-14 10:18 am Purchase | 2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 463,776 9.990% | 120,720 (+35.19%) | Filing History |
| 2024-02-14 10:16 am Sale | 2023-12-31 | 13G | Cullinan Therapeutics, Inc. CGEM | BIOTECHNOLOGY VALUE FUND L P | 4,393,321 9.990% | -3,115,738 (-41.49%) | Filing History |